About Us Services Careers FAQ Contact Us 0
Home Biotechnology Mononucleosis Diagnostic Market Size to Register at a CAGR of 9.4% by 2032
Mononucleosis Diagnostic Market

Mononucleosis Diagnostic Market Size, Share & Trends Analysis Report By Test Type (Epstein Barr Virus (EBV) Antibody Test, Monospot Test, Complete Blood Count Test), By End-User (Hospitals, Laboratories) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRBI56020DR
Last Updated : April 23, 2024
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Mononucleosis Diagnostic Market Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Epstein Barr Virus (EBV) Antibody Test
        1. By Value
      3. Monospot Test
        1. By Value
      4. Complete Blood Count Test
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Laboratories
        1. By Value
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Epstein Barr Virus (EBV) Antibody Test
        1. By Value
      3. Monospot Test
        1. By Value
      4. Complete Blood Count Test
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Laboratories
        1. By Value
    4. U.S.
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Epstein Barr Virus (EBV) Antibody Test
          1. By Value
        3. Monospot Test
          1. By Value
        4. Complete Blood Count Test
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Laboratories
          1. By Value
    5. Canada
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Epstein Barr Virus (EBV) Antibody Test
        1. By Value
      3. Monospot Test
        1. By Value
      4. Complete Blood Count Test
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Laboratories
        1. By Value
    4. U.K.
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Epstein Barr Virus (EBV) Antibody Test
          1. By Value
        3. Monospot Test
          1. By Value
        4. Complete Blood Count Test
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Laboratories
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Epstein Barr Virus (EBV) Antibody Test
        1. By Value
      3. Monospot Test
        1. By Value
      4. Complete Blood Count Test
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Laboratories
        1. By Value
    4. China
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Epstein Barr Virus (EBV) Antibody Test
          1. By Value
        3. Monospot Test
          1. By Value
        4. Complete Blood Count Test
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Laboratories
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Singapore
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Epstein Barr Virus (EBV) Antibody Test
        1. By Value
      3. Monospot Test
        1. By Value
      4. Complete Blood Count Test
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Laboratories
        1. By Value
    4. UAE
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Epstein Barr Virus (EBV) Antibody Test
          1. By Value
        3. Monospot Test
          1. By Value
        4. Complete Blood Count Test
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Laboratories
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Epstein Barr Virus (EBV) Antibody Test
        1. By Value
      3. Monospot Test
        1. By Value
      4. Complete Blood Count Test
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Laboratories
        1. By Value
    4. Brazil
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Epstein Barr Virus (EBV) Antibody Test
          1. By Value
        3. Monospot Test
          1. By Value
        4. Complete Blood Count Test
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Laboratories
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Mononucleosis Diagnostic Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Abbott (U.S.)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. DAIICHI SANKYO COMPANY, LIMITED (Japan)
    3. Weizmann Institute of Science (Israel)
    4. Biotest AG (Germany)
    5. Bio-Rad Laboratories, Inc. (U.S.)
    6. Genzyme (U.S.)
    7. F. Hoffmann-La Roche Ltd (Switzerland)
    8. Johnson & Johnson Services, Inc. (U.S.)
    9. BD (U.S.)
    10. DiaSorin Molecular LLC (U.S.)
    11. Beckman Coulter, Inc. (U.S.)
    12. bioMérieux (France)
    13. Siemens (Germany)
    14. Sekisui Diagnostics (U.S.)
    15. ELITechGroup (France)
    16. Cardinal Health (U.S.)
    17. Immunostics Inc. (U.S.)
    18. Meridian Bioscience (U.S.)
    19. Thermo Fischer Scientific Inc. (U.S.)
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global sepsis diagnostics market size was valued at USD 685 million in 2022. It is expected to reach USD 1,427.44 million by 2031 at a CAGR of 8.5% during the projected period (2023–2031). Factors such as increasing prevalence of
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.